Profile
Walter C.
Ogier founded Acetylon Pharmaceuticals, Inc. in 2008, where he worked as President & Director from 2008 to 2016.
Mr. Ogier also currently works at Biothera, Inc., as Director and Thetis Pharmaceuticals LLC, as Director from 2016.
Mr. Ogier also formerly worked at Eligix, Inc., as President & Chief Executive Officer from 1997 to 2001, Arbios Systems, Inc., as President & Chief Executive Officer from 2005 to 2007, bluebird bio, Inc., as President & Chief Executive Officer from 2001 to 2005, Regenacy Pharmaceuticals LLC, as President & Chief Executive Officer from 2016 to 2020, Anelixis Therapeutics, Inc., as Chairman from 2017 to 2020, Baxter Healthcare Corp., as Director-Business Development from 1987 to 1994, IRX Therapeutics, Inc., as Director in 2018, AccuMed, Inc., as Director, Nemucore Medical Innovations, Inc., as Director from 2018 to 2022, Biothera Pharmaceuticals, Inc. (Delaware), as Director from 2014 to 2020, Eledon Pharmaceuticals, Inc., as Independent Director from 2020 to 2024, Vericel Corp., as Vice President-Marketing from 1994 to 1997, and SRI International, as Principal.
Mr. Ogier received his undergraduate degree in 1979 from Williams College and Masters Business Admin degree in 1987 from Yale School of Management.
Walter Ogier active positions
| Companies | Position | Start |
|---|---|---|
Thetis Pharmaceuticals LLC
Thetis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug development services | Director/Board Member | 01/01/2016 |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Director/Board Member | - |
Former positions of Walter Ogier
| Companies | Position | End |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Director/Board Member | 10/07/2024 |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes life saving nanomedicines for the treatment of MDR cancers | Director/Board Member | 01/04/2022 |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Director/Board Member | 01/09/2020 |
Anelixis Therapeutics, Inc.
Anelixis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune modulatory drugs for neurodegenerative diseases | Chairman | 01/09/2020 |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops novel treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors | Chief Executive Officer | 01/03/2020 |
Training of Walter Ogier
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Vericel Corp.
Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Eligix, Inc.
Eligix, Inc. Medical/Nursing ServicesHealth Services Develops and distributes medicines | Health Services |
Arbios Systems, Inc.
Arbios Systems, Inc. Medical SpecialtiesHealth Technology Develops proprietary medical devices and cell-based therapies | Health Technology |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
SRI International
SRI International Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Commercial Services |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
AccuMed, Inc.
AccuMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical tablets, powders, liquids & edible breath strip products | Health Technology |
Williams College
Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technology | Health Technology |
Thetis Pharmaceuticals LLC
Thetis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes life saving nanomedicines for the treatment of MDR cancers | Health Technology |
Yale School of Management
Yale School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Health Services |
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Anelixis Therapeutics, Inc.
Anelixis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune modulatory drugs for neurodegenerative diseases | Health Technology |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops novel treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors | Health Technology |
- Stock Market
- Insiders
- Walter Ogier
















